•
Mar 31

PTC Therapeutics Q2 2025 Earnings Report

Expected Revenue:$NaN
NaN% YoY
Expected EPS:$NaN
NaN% YoY
Total Revenue
$1.18B
Previous year: $210M
+459.7%
Gross Profit
$1.16B
Previous year: $144M
+706.0%
Cash and Equivalents
$2.03B
Previous year: $885M
+129.1%
Free Cash Flow
$868M
Previous year: $61.2M
+1319.5%
Total Assets
$2.66B
Previous year: $1.79B
+48.4%

PTC Therapeutics

PTC Therapeutics